Pevzner Alina M, Tsyganov Matvey M, Ibragimova Marina K, Litvyakov Nikolai V
Research Institute of Oncology, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Radiat Oncol J. 2021 Dec;39(4):247-253. doi: 10.3857/roj.2021.00115. Epub 2021 Oct 25.
This review is devoted to a rare in clinical practice, but promising phenomenon of regression distant non-irradiated metastases in combination therapy of cancer patients. R. H. Mole in 1953 suggested introducing the term "abscopal effect" to denote the effect of ionizing radiation "at a distance from the irradiated volume but within the same organism." Currently, it is a hypothesis in the treatment of metastatic cancer, when there is a regression of untreated areas simultaneously with a decrease in the tumor. After the discovery of immune checkpoint cases were increase with patients treated with check-point blockade (especially lymphocyte associated protein 4, programmed cell death 1/programmed cell death 1 ligand 1) and which have an abscopal effect. This review systematizes works covering the time period from 1969 to 2019, which give cases of the abscopal effect at different localizations. However, abscopal effect is a poorly understood phenomenon. In this review, the authors tried to collect all information about the possible mechanisms of the abscopal effect, possible role in antitumor response and frequency abscopal effect at radio/immunotherapy or combined both.
本综述致力于探讨癌症患者联合治疗中一种临床实践中罕见但很有前景的现象,即远处未受照射的转移灶发生消退。1953年,R. H. 莫尔建议引入“远隔效应”一词,以表示电离辐射“在距受照射区域一定距离但在同一生物体内”产生的效应。目前,这是转移性癌症治疗中的一种假说,即在肿瘤缩小的同时,未治疗区域也出现消退。在发现免疫检查点后,接受检查点阻断治疗(尤其是淋巴细胞相关蛋白4、程序性细胞死亡蛋白1/程序性细胞死亡蛋白1配体1)且出现远隔效应的患者病例有所增加。本综述对1969年至2019年期间涉及不同部位远隔效应病例的研究进行了系统梳理。然而,远隔效应是一种尚未被充分理解的现象。在本综述中,作者试图收集有关远隔效应可能机制、在抗肿瘤反应中的可能作用以及在放射治疗/免疫治疗或两者联合治疗中远隔效应发生频率的所有信息。